To: Mike McFarland who wrote (470 ) 3/13/2000 10:38:00 PM From: Micro-Selector Read Replies (1) | Respond to of 743
POSC currently less than $1 IMAT recently acquired majority of shares. Looks like synergy and leadership is starting to pay off. ****************************************************** Mobile P.E.T. Systems Unveils First Mobile Cardiac PET System At ACC 2000 Convention in Anaheim, March 12-15 SAN DIEGO--(BW HealthWire)--March 13, 2000--Mobile P.E.T. Systems Inc. (OTCBB: MBPT), announced today that it will exhibit the first mobile cardiac positron emission tomography (PET) system dedicated for use by cardiologists at the American College of Cardiology convention at the Anaheim Convention Center starting on Sunday, March 12. Paul Crowe, chief executive officer, said, "We are delighted to offer this new delivery approach utilizing a mobile shared service for cardiologists which will be used to diagnose cardiovascular disease to a broader patient population. In conjunction with this exhibit, Mobile P.E.T. will be contracting its first service route with hospitals in the Los Angeles and Orange County areas." Mobile P.E.T. Systems, Positron Corp. (OTCBB: POSC), Bracco Diagnostics and Calumet Coach Works jointly developed this first dedicated mobile cardiac PET unit. Positron Corp., based in Houston, is the leading manufacturer of cardiac PET systems and software. Bracco Diagnostics Inc., based in Milan, Italy, and Princeton, New Jersey, is the producer of Rubidium-82, the myocardial perfusion imaging agent for the PET procedure. Calumet Coach Works, based in Calumet City, Illinois, performed integration of the cardiac PET imaging system into a specially designed medical trailer. About PET Positron emission tomography is an advanced molecular imaging procedure that provides a means for early diagnosis of diseases including cancer and heart disease by direct measurement of biochemistry and metabolic activity. PET myocardial perfusion imaging (MPI) allows cardiologists to manage coronary artery disease patients directly because of its superior imaging capabilities. PET technology makes an appropriate adjustment for patients' body size, bone structure and fat deposits; whereas conventional nuclear imaging does not. This procedure contributes to a higher predictive accuracy allowing physicians greater clinical reliability. Studies have demonstrated that PET reduces overall costs of coronary artery disease management by reducing unnecessary coronary angiograms and bypass operations, and by avoiding adverse clinical outcomes of coronary heart disease such as premature death and myocardial infarction. In 1995 HCFA approved reimbursement for PET MPI with Rubidium-82. About Mobile P.E.T. Systems Inc. Mobile P.E.T. Systems Inc. provides shared PET services to hospitals and other health care providers on a contractual basis. Mobile PET's services include the PET imaging system and trained nuclear medicine technologists, providing a cost-effective approach to PET for interim or long-term shared services. For further information see the company's Web site at www.mobilepet.com. Certain statements contained in this press release may be "forward-looking statements" within the meaning of the Private Securities Legislation Reform Act of 1966, including, without limitation, anything relating or referring to financial results and plans for future business development activities, and are thus prospective.